Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment

In head and neck cancer management, there is a need for tailored approaches to optimally implement clinical outcomes. Based on the assumption that efficacy and long-term toxicity are not satisfactory for standard concurrent platinum-based chemoradiotherapy, several trials have been designed to test...

Descripción completa

Detalles Bibliográficos
Autores principales: De Felice, Francesca, Musio, Daniela, Tombolini, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151395/
https://www.ncbi.nlm.nih.gov/pubmed/34068797
http://dx.doi.org/10.3390/jpm11050393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151395/
https://www.ncbi.nlm.nih.gov/pubmed/34068797
http://dx.doi.org/10.3390/jpm11050393

Ejemplares similares